Skip to main content

Following spike in hospitalizations, Maryland provides surge of money to overburdened hospitals

The flu and COVID season has been a tough one for Marylanders. State leaders say about 4,000 residents have been hospitalized with the flu this year, another 1,000 with RSV and hundreds more with COVID.

It’s put a strain on Maryland’s hospitals and led Gov. Wes Moore to announce Thursday the state will provide $164 million to hospitals around the state to help those facilities care for the influx in patients.

“This funding will make sure that hospitals have support to be able to cover the costs of additional staff,” Moore said. “It will make sure that hospitals have the ability to keep beds open and available.”

Maryland Health Secretary Dr. Meena Seshamani said the level of respiratory illnesses remains high after a recent spike in hospitalizations.

“We are still high,” Seshamani said during an event at University of Maryland Capital Region Health in Largo. “Even when a spike starts to come down, there can be another spike, because people start to relax and say, ‘OK, we’re through that hump’ and maybe hand washing, other things kind of fall back a little bit.”

Nat Richardson, the president and CEO of the University of Maryland hospital in Largo, said his organization plans and budgets for increased needs at this time of year brought on by illnesses such as the flu. However, this year has been overwhelming.

“When you think about a 30% surge in hospitals — that surge, we can’t just go in a closet and pick up a bunch of team members and say, ‘Come help with the surge,’” Richardson said. “We’re typically reaching out to agencies … to bring in additional resources. And those are dollars that we plan for, for the most part, but not at a 30% surge.”

State leaders also kept hammering home the point that vaccines of all kinds, but especially flu and COVID shots, are safe and effective. Officials have said even if the vaccines don’t stop someone from getting sick, they reduce the impact the virus will have on you.

“The confusion stops here,” Seshamani said. “It is worth it. Vaccines are one of the most powerful tools in our toolbox to keep ourselves healthy. They continue to be the most effective way to protect ourselves and our families against severe illness, and that includes the strains of flu that are circulating now.”

Tools to fight hantavirus show promise despite limited funding. Now researchers hope to continue

SANTIAGO, Chile (AP) — When a rare but deadly rodent-borne virus struck passengers on a cruise ship and seemed to be spreading, there were no treatments for those who fell ill and no vaccines to protect others. That was the case even though it wasn't a novel germ that the world had never seen before, like the virus that caused the coronavirus pandemic. It was a hantavirus, one of a family of viruses that have been known for decades and are thought to exist around the world. Teams of researchers, including in Chile, Argentina and the United States, have long been trying to find and develop drugs and vaccines. But because the viruses are relatively rare and don't spread easily between people, there hasn't been enough sustained investment by governments, global health groups, or drug companies to pay for the extensive safety and efficacy testing needed to make them available. Still, there have been some promising developments. Researchers on Wednesday published a hint that a drug used for an autoimmune disease may help hantavirus patients fight off the most deadly symptoms.
Read Next Story